# Nisarga Biotech Private Ltd · 99-39 · INDIA — FDA import alert red lists: firms subject to detention without physical examination

For Nisarga Biotech Private Ltd · 99-39 · INDIA, import alert is 99-39; import alert name is Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded; country is INDIA; product is Ocimum Sanctum Extract; product code is 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C; date published is 02/14/2017; address is J2/1 Additional Midc , Satara, Maharashtra INDIA, verified against its source on 2026-09-16.

- **Firm:** Nisarga Biotech Private Ltd _(verified: appears in the quote below)_
- **Import alert:** 99-39
- **Import alert name:** Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
- **Country:** INDIA _(verified: appears in the quote below)_
- **Address:** J2/1 Additional Midc , Satara, Maharashtra INDIA _(verified: appears in the quote below)_
- **Date published:** 02/14/2017 _(verified: appears in the quote below)_
- **Product code:** 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. _(verified: appears in the quote below)_
- **Product:** Ocimum Sanctum Extract _(verified: appears in the quote below)_
- **FDA notes:** The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of Section 403(a)(1) of the Act [21 U.S.C. § 343(a)(1)], in that the labeling is false or misleading in any particular. Specifically, the product label fails to indicate the presence of ricinine. _(verified: appears in the quote below)_

## What the source says

> Nisarga Biotech Private Ltd Date Published : 02/14/2017 J2/1 Additional Midc , Satara, Maharashtra INDIA 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. Date Published: 02/14/2017 Desc: Ocimum Sanctum Extract Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product appears to be misbranded within the meaning of Section 403(a)(1) of the Act [21 U.S.C. § 343(a)(1)], in that the labeling is false or misleading in any particular. Specifically, the product label fails to indicate the presence of ricinine.

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_1144.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).